Extraintestinal Manifestations in Irritable Bowel Syndrome: A Systematic Review

Overview

Journal Therap Adv Gastroenterol

Publisher Sage Publications

Specialty Gastroenterology

Date 2022 Aug 15

PMID 35967918

Authors

Bodil Ohlsson

Affiliations

Soon will be listed here.

Abstract

Background: Irritable bowel syndrome (IBS) is characterized by abdominal pain and altered bowel habits. Further, IBS patients experience a high degree of extraintestinal symptoms.

Objectives: The aim of this review was to describe the relation between IBS and extraintestinal manifestations and mechanisms and treatments of these extraintestinal manifestations.

Design: The study was performed as a systematic review.

Data Sources And Methods: Search terms including extraintestinal manifestations or somatization and IBS were used to scrutinize for publications in Pubmed. In total, 630 publications were identified and 80 were finally included in this review.

Results: About 50% of all IBS patients have extraintestinal manifestations in addition to gastrointestinal symptoms. Somatic pain, fatigue, and sleeping disturbances are most common, and most often described in women. Both extraintestinal manifestations and psychological distress are associated with exaggerated gastrointestinal symptoms, impaired quality of life, and difficulties to treat IBS symptoms. The extraintestinal manifestations render an excess of healthcare costs. Varying etiology and pathophysiology to IBS are discussed, and many patients express a general hypersensitivity. Extraintestinal symptoms are seldom documented at clinical healthcare or included in the assessment of treatment outcomes. A good patient-physician relationship and strengthening of coping mechanisms have rendered less gastrointestinal symptoms, psychological distress, and somatization. Altered lifestyle habits may improve both gastrointestinal and extraintestinal symptoms. Pharmacological treatment, including antidepressant drugs, should be considered when lifestyle advice fails. Teamwork between different specialists and healthcare providers may be of importance in the wide range of symptoms and extraintestinal manifestations.

Conclusion: Extraintestinal manifestations are common in IBS patients and is associated with worse suffering and difficulties to treat symptoms. Evaluation and treatment of IBS patients should consider also extraintestinal manifestations and their treatment outcome. Establishment of good relationship, strengthening of coping mechanisms, and education in healthier lifestyle habits are crucial in the management of these patients.

Citing Articles

Acute stress triggers sex-dependent rapid alterations in the human small intestine microbiota composition.

Rodino-Janeiro B, Khannous-Lleiffe O, Pigrau M, Willis J, Salvo-Romero E, Nieto A Front Microbiol. 2025; 15:1441126.

PMID: 39881982 PMC: 11778178. DOI: 10.3389/fmicb.2024.1441126.

Long-term symptoms in children after a Cryptosporidium hominis outbreak in Sweden: a 10-year follow-up.

Boks M, Lilja M, Lindam A, Widerstrom M, Persson A, Karling P Parasitol Res. 2025; 124(1):13.

PMID: 39862254 PMC: 11762772. DOI: 10.1007/s00436-025-08455-7.

Fibromyalgia severity and symptoms are associated with the disorders of gut-brain interaction.

Erdrich S, Harnett J Eur J Pain. 2024; 29(1).

PMID: 39665371 PMC: 11635909. DOI: 10.1002/ejp.4766.

Economic Evaluations of Non-Pharmacological Interventions for Treating Disorders of Gut-Brain Interaction: A Scoping Review.

Pak A, OGrady M, Holtmann G, Shah A, Tuffaha H Pharmacoeconomics. 2024; 43(3):249-269.

PMID: 39570568 DOI: 10.1007/s40273-024-01455-y.

Investigating the effects of combined treatment of mesalazine with in the experimental model of ulcerative colitis.

Bahrami S, Babaei N, Esmaeili Gouvarchin Ghaleh H, Mohajeri Borazjani J, Farzanehpour M Front Mol Biosci. 2024; 11:1456053.

PMID: 39421689 PMC: 11484277. DOI: 10.3389/fmolb.2024.1456053.

References

Vege S, Richard Locke 3rd G, Weaver A, Farmer S, Melton 3rd L, Talley N . Functional gastrointestinal disorders among people with sleep disturbances: a population-based study. Mayo Clin Proc. 2004; 79(12):1501-6. DOI: 10.4065/79.12.1501. View

Chang L, Sundaresh S, Elliott J, Anton P, Baldi P, Licudine A . Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterol Motil. 2008; 21(2):149-59. PMC: 2745840. DOI: 10.1111/j.1365-2982.2008.01171.x. View

Waehrens R, Ohlsson H, Sundquist J, Sundquist K, Zoller B . Risk of irritable bowel syndrome in first-degree, second-degree and third-degree relatives of affected individuals: a nationwide family study in Sweden. Gut. 2014; 64(2):215-21. DOI: 10.1136/gutjnl-2013-305705. View

Undseth R, Berstad A, Valeur J . Systemic symptoms in irritable bowel syndrome: An investigative study on the role of enterocyte disintegrity, endotoxemia and inflammation. Mol Med Rep. 2016; 14(6):5072-5076. PMC: 5355706. DOI: 10.3892/mmr.2016.5878. View

Black C, Yiannakou Y, Houghton L, Shuweihdi F, West R, Guthrie E . Anxiety-related factors associated with symptom severity in irritable bowel syndrome. Neurogastroenterol Motil. 2020; 32(8):e13872. DOI: 10.1111/nmo.13872. View

Park J, Choi M, Cho Y, Lee I, Kim J, Kim S . Functional Gastrointestinal Disorders Diagnosed by Rome III Questionnaire in Korea. J Neurogastroenterol Motil. 2011; 17(3):279-86. PMC: 3155064. DOI: 10.5056/jnm.2011.17.3.279. View

Mearin F, Lacy B, Chang L, Chey W, Lembo A, Simren M . Bowel Disorders. Gastroenterology. 2016; . DOI: 10.1053/j.gastro.2016.02.031. View

Noble H, Hasan S, Whorwell P, Vasant D . The symptom burden of Irritable Bowel Syndrome in tertiary care during the COVID-19 pandemic. Neurogastroenterol Motil. 2022; 34(9):e14347. PMC: 9115346. DOI: 10.1111/nmo.14347. View

Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L, Hungin P . Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut. 2007; 56(12):1770-98. PMC: 2095723. DOI: 10.1136/gut.2007.119446. View

10.

Schwille-Kiuntke J, Enck P, Zendler C, Krieg M, Polster A, Klosterhalfen S . Postinfectious irritable bowel syndrome: follow-up of a patient cohort of confirmed cases of bacterial infection with Salmonella or Campylobacter. Neurogastroenterol Motil. 2011; 23(11):e479-88. DOI: 10.1111/j.1365-2982.2011.01779.x. View

11.

Vu J, Kushnir V, Cassell B, Gyawali C, Sayuk G . The impact of psychiatric and extraintestinal comorbidity on quality of life and bowel symptom burden in functional GI disorders. Neurogastroenterol Motil. 2014; 26(9):1323-32. DOI: 10.1111/nmo.12396. View

12.

Darwiche G, Hoglund P, Roth B, Larsson E, Sjoberg T, Wohlfart B . An Okinawan-based Nordic diet improves anthropometry, metabolic control, and health-related quality of life in Scandinavian patients with type 2 diabetes: a pilot trial. Food Nutr Res. 2016; 60:32594. PMC: 5035506. DOI: 10.3402/fnr.v60.32594. View

13.

Sperber A, Bangdiwala S, Drossman D, Ghoshal U, Simren M, Tack J . Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology. 2020; 160(1):99-114.e3. DOI: 10.1053/j.gastro.2020.04.014. View

14.

Levy R, von Korff M, Whitehead W, Stang P, Saunders K, Jhingran P . Costs of care for irritable bowel syndrome patients in a health maintenance organization. Am J Gastroenterol. 2001; 96(11):3122-9. DOI: 10.1111/j.1572-0241.2001.05258.x. View

15.

Lakhan S, Schofield K . Mindfulness-based therapies in the treatment of somatization disorders: a systematic review and meta-analysis. PLoS One. 2013; 8(8):e71834. PMC: 3753315. DOI: 10.1371/journal.pone.0071834. View

16.

Bengtsson M, Hammar O, Mandl T, Ohlsson B . Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS). BMC Gastroenterol. 2011; 11:122. PMC: 3248355. DOI: 10.1186/1471-230X-11-122. View

17.

Agrawal A, Khan M, Whorwell P . Irritable bowel syndrome in the elderly: An overlooked problem?. Dig Liver Dis. 2009; 41(10):721-4. DOI: 10.1016/j.dld.2009.03.011. View

18.

Latremoliere A, Woolf C . Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009; 10(9):895-926. PMC: 2750819. DOI: 10.1016/j.jpain.2009.06.012. View

19.

Bjorkman I, Jakobsson Ung E, Ringstrom G, Tornblom H, Simren M . More similarities than differences between men and women with irritable bowel syndrome. Neurogastroenterol Motil. 2015; 27(6):796-804. DOI: 10.1111/nmo.12551. View

20.

Roth B, Larsson E, Ohlsson B . Poor intake of vitamins and minerals is associated with symptoms among patients with irritable bowel syndrome. J Gastroenterol Hepatol. 2022; 37(7):1253-1262. PMC: 9544605. DOI: 10.1111/jgh.15830. View